Clinical trial
A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With…
NCT00174785 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00174785 |
|---|---|
| Title | A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation |
| Official title | A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL) |
| Acronym | ATHENA |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Atrial Flutter |
| Intervention type | Drug |
| Interventions | dronedarone (SR33589), placebo |
| Enrollment | 4,628 |
| Start date | Jun 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 12, 2010 |
| Countries | Argentina, Australia, Austria, Belgium, Canada, Chile, China, Czechia, Finland, Germany, Greece, Hong Kong and 25 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: